Neurizon Therapeutics Reports Positive NUZ-001 Study
Neurizon Therapeutics (ASX: NUZ) has announced encouraging outcomes from an independent study assessing its neuroprotective ...
Small Caps1d
Neurizon Therapeutics reports positive study results on human brain model by neuroprotective candidate NUZ-001
Neurizon Therapeutics (ASX: NUZ) has reported positive results from an independent study into the effects of neuroprotective ...
Stockhead on MSN1d
StockTake: Neurizon’s potential cure for Alzheimer’s
Neurizon teams up with Tessara for further testing on its ... Read More The post StockTake: Neurizon’s potential cure for ...
HotCopper on MSN2d
Neurizon finds positive results for lead drug in 3D brain model study
Neurizon Therapeutics Ltd (ASX:NUZ) has yielded positive results from an independent study – conducted in collaboration with ...
Stockhead2d
Health Check: It’s a CEO changing of the guard at Mach 7 and Universal Biosensors
Mach 7 and Universal Biosensors have announced their CEOs will depart, while changes at the top are likely at other biotechs.
ALS News Today5d
NUZ-001 slows decline in ALS lung function, Phase 1 trial shows
NUZ-001 slowed respiratory declines in ALS patients in a Phase 1 trial, and Neurizon is working to ready it for the HEALEY ...
Stockhead7d
Top of mind: ASX companies tackling neurological disorders
Several ASX healthcare companies are leading the charge in finding new treatments for complex neurological disorders.
Break it Down: One step closer to treating ALS
Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episode, Tylah Tully gives the ...
Northern Territory News13d
Long Shortz with Neurizon Therapeutics: Clinical hold lift on the horizon
Neurizon Therapeutics plans to implement several initiatives to get the clinical hold lifted of its IND application for NUZ-001. The company has been in discussion with the US FDA since February ...